Antitumor concomitant resistance;Resistencia concomitante antitumoral

Medicina

Volumn 56, Issue SUPPL. 1, 1996, Pages 57-64

  Ruggiero, Raul A ^a   Di Gianni, Pedro D ^a   Franco, Marcela ^a   Bustuoabad, Oscar D ^a  

^a INST DE INVEST HEMATOLOGICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; BLOOD; CANCER TRANSPLANTATION; IMMUNOLOGY; INNATE IMMUNITY; METASTASIS; MOUSE; NEOPLASM; NUDE MOUSE; PATHOLOGY;

ANIMALS; IMMUNITY, NATURAL; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASMS;

EID: 3142647367     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ehrlich P. Experimentelle Carcinomstudien an Mausen: In: Arbeiten aus dem Koiglichen Institut fur Experimentelle Therapie zu Frankfurt/AM, Ehrlich P (ed) Jena: Fisher, 1906; 77-103.
2. Bashford E, Murray J, Haaland M. General results of propagation of malignant new growths. In: Bashford (ed). Third scientific report on the investigation of the Imperial Cancer Research Fund. London: Taylorand Francis, 1908; 262-8.
3. Lange PH, Hekmat K, Bosl G, et al. Accelerated growth of testicular cancer after cytoreductive surgery. Cancer, 1980; 45: 1498-506.
4. Southam CM. Co-existence of allogeneic tumour growth and homograft immunity in man. Europ J Cancer 1968; 4: 507-11.
5. Gorelik E. Concomitant tumor immunity and the resistance to a second tumor challenge. Adv Cancer Res. 1983; 39: 71-120.
6. Sugarbaker EV, Thornthwaite J, Ketchan AS. Inhibitory effect of a primary tumor on metastasis. In: Day SB (ed). Cancer Invasion and Metastasis, New York: Raven Press, 1977: 227-40.
7. Akporiaye ET, Kudalore M, Stevenson AP, et al. Isolation and reactivity of host effectors associated with the manifestation of concomitant tumor immunity. Cancer Res 1988; 48: 1153-8.
8. Belehradek J, Barski G, Thonier M. Evolution of cell-mediated antitumor immunity in mice bearing a syngeneic chemically induced tumor. Influence of tumor growth, surgical removal and treatment with irradiated tumor cells. Int J Cancer. 1972; 9: 461-9.
9. North RJ. Down-regulation of the antitumor immune response. Adv Cancer Res. 1985; 45: 1-43.
10. Gorelik E, Segal S, Feldman M. On the mechanism of tumor «concomitant immunity». Int J Cancer 1981; 27: 847-56.
11. Yuhas JM, Pazmiño NH, Wagner E. Development of concomitant immunity in mice bearing the weakly immunogenic line 1 lung carcinoma. Cancer Res 1975; 35: 237-41.
12. Hewitt HB, Blake ER, Walder AS. A critique of the evidence for active host defence against cancer based on personal studies of 27 murine tumours of spontaneous origin. Br J Cancer. 1976; 33: 241-59.
13. Middle JG, Embleton MJ. Naturally arising tumours of the inbred WAB/Not rat strain II. Immunogenicity of transplanted tumours. J Natl Cancer Inst 1981; 67: 637-43.
14. Bonfil RD, Ruggiero RA, Bustuoabad OD, et al. Role of concomitant resistance in the development of murine lung metastases. Int J Cancer 1988; 41: 415-22.
15. Franco M, Bustuoabad OD, di Gianni PD, et al. A serum-mediated mechanism for concomitant resistance shared by immunogenic and non-immunogenic murine tumors. Br J Cancer 1996; 74: 178-186.
16. Meiss RP, Bonfil RD, Ruggiero RA, Pasqualini CD. Histologic aspects of concomitant resistance induced by non-immunogeneic murine tumors. J Natl Cancer Inst 1986; 76: 1163-75.
17. Ruggiero RA, Bustuoabad OD, Bonfil RD, et al. «Concomitant immunity» in murine tumors of non-detectable immunogenicity. Br J Cancer 1985; 51: 37-48.
18. Ruggiero RA, Bustuoabad OD, Cramer P, et al. Correlation between seric antitumor activity and concomitant resistance in mice bearing nonimmunogenic tumors. Cancer Res 1990; 50: 7159-65.
19. Tuttle RL, Knick VC, Stopford CR, Wolberg G. In vivo and in vitro antitumor activity expressed by cells of concomitantly immune mice. Cancer Res 1983; 43: 2600-5.
20. Beutler B, Cerami A. Cachectin and tumor neucrosis factor as two sides of the same biological coin. Nature 1986; 320: 584-8.
21. Keski-Oja J, Postlethwaite AE, Moses HL. Transforming growth factors in the regulation of malignant cell growth and invasion. Cancer Investigation 1988; 6: 704-24.
22. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79: 315-28.
23. Trincheri G, Perussia B. Immune Interferon: a pleotropic lymphokine with multiple effects. Immunol Today 1985; 6: 131-6.
24. Gershon RK, Carter RL, Kondo K. On concomitant immunity in tumor-bearing hamsters. Nature. 1967; 213: 674-6.
25. Vaage J, Agarwal S. Serum therapy for radiation-induced impairment of immune resistance to metastases. Cancer Res 1977; 37: 3556-60.
26. Woglom WH. Immunity to transplantabte tumours. Cancer Rev 1929; 4: 129-209.
27. Jirtle RL, Michalopoulos G. Effects of partial hepatectomy on transplanted hepatocytes. Cancer Res 1982; 42: 3000-4.
28. Gorelik E. Antimetastatic concomitant immunity. In: Liotta LA, Hart JR (eds). Tumor Invasion and Metastasis. The Hague: Martinus Nijhoff Publishers, 1982: 113-31.
29. Bresnick E. Regenerating liver: an experimental model for the study of growth. Methods Cancer Res. 1971; 6: 347-97.
30. Moolten FL, Bucker NLR. Regeneration of rat liver: transfer of humoral agent by cross-circulation. Science 1967; 158: 272-4.